Display options
Cite
Erdem A, Ceylan US, Esen A, et al. Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis. Int J Gen Med. 2016;9:319-24doi: 10.2147/IJGM.S109452.
Erdem, A., Ceylan, U. S., Esen, A., Zencirci, E., Topcu, B., Ozden, K., Yazici, S., Terzi, S., Emre, A., & Yesilcimen, K. (2016). Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis. International journal of general medicine, 9319-24. https://doi.org/10.2147/IJGM.S109452
Erdem, Aysun, et al. "Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis." International journal of general medicine vol. 9 (2016): 319-24. doi: https://doi.org/10.2147/IJGM.S109452
Erdem A, Ceylan US, Esen A, Zencirci E, Topcu B, Ozden K, Yazici S, Terzi S, Emre A, Yesilcimen K. Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis. Int J Gen Med. 2016 Sep 09;9:319-24. doi: 10.2147/IJGM.S109452. eCollection 2016. PMID: 27672339; PMCID: PMC5024766.
Copy Download .nbib Format: NLM
Share it on

Int J Gen Med. 2016 Sep 09;9:319-24. doi: 10.2147/IJGM.S109452. eCollection 2016.

Clinical usefulness of red cell distribution width to angiographic severity and coronary stent thrombosis.

International journal of general medicine

Aysun Erdem, Ufuk Sadik Ceylan, Aycan Esen, Ertugrul Zencirci, Birol Topcu, Kivilcim Ozden, Selcuk Yazici, Sait Terzi, Ayse Emre, Kemal Yesilcimen

Affiliations

  1. Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
  2. Department of Cardiology, Acibadem Hospital Maslak, Istanbul, Turkey.
  3. Department of Biostatistics, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.

PMID: 27672339 PMCID: PMC5024766 DOI: 10.2147/IJGM.S109452

Abstract

BACKGROUND: Red cell distribution width (RDW) is a quantitative measurement and shows heterogeneity of red blood cell size in peripheral blood. RDW has recently been associated with cardiovascular events and cardiovascular diseases, and it is a novel predictor of mortality. In this study, we aimed to evaluate the clinical usefulness of measuring RDW in patients with coronary stent thrombosis.

PATIENTS AND METHODS: We retrospectively reviewed 3,925 consecutive patients who presented with acute coronary syndrome and who underwent coronary angiography at the Siyami Ersek Hospital between May 2011 and December 2013. Of the 3,925 patients, 73 patients (55 males, mean age 59±11 years, 55 with ST elevated myocardial infarction) with stent thrombosis formed group 1. Another 54 consecutive patients who presented with acute coronary syndrome (without coronary stent thrombosis, 22 patients with ST elevated myocardial infarction, 44 males, mean age 54±2 years) and underwent percutaneous coronary intervention in May 2011 formed group 2. Data were collected from all groups for 2 years. The RDW values were calculated from patients 1 month later at follow-up. Syntax scores were calculated for all the patients. The patients were also divided as low syntax score group and moderate-high syntax score group.

RESULTS: The patients in group 1 with stent thrombosis had significantly higher RDW level (13.85) than the patients in group 2 without stent thrombosis (12) (P<0.001). In addition, in all study patients, the moderate-high syntax score group had significantly higher RDW level (13.6) than the low syntax score group (12.9) (P=0.009). A positive correlation was determined between RDW and syntax scores (r=0.204).

CONCLUSION: RDW is a new marker of poor prognosis in coronary artery disease. Increased RDW level is correlated with angiographic severity of coronary artery disease, and RDW may be an important clinical marker of coronary stent thrombosis in patients undergoing coronary intervention.

Keywords: coronary artery disease; red cell distribution width; stent thrombosis; syntax score

References

  1. Eur J Heart Fail. 2009 Dec;11(12):1155-62 - PubMed
  2. Thromb Haemost. 2009 Sep;102(3):581-7 - PubMed
  3. PLoS One. 2014 Apr 10;9(4):e94887 - PubMed
  4. Diabetologia. 2012 Jan;55(1):226-35 - PubMed
  5. BMJ. 2008 Jan 26;336(7637):166-7 - PubMed
  6. BMJ. 2008 Jan 26;336(7637):195-8 - PubMed
  7. Clin Hemorheol Microcirc. 2012;51(4):243-54 - PubMed
  8. Cardiology. 2011;119(2):72-80 - PubMed
  9. Clin Chem Lab Med. 2011 Dec 17;50(4):635-41 - PubMed
  10. Eur Heart J. 2010 Oct;31(20):2501-55 - PubMed
  11. J Gerontol A Biol Sci Med Sci. 2010 Mar;65(3):258-65 - PubMed
  12. Am J Cardiol. 2012 Oct 1;110(7):924-32 - PubMed
  13. Clin Chem Lab Med. 2009;47(3):353-7 - PubMed
  14. Circulation. 2007 Oct 23;116(17):1952-65 - PubMed
  15. Exp Clin Cardiol. 2010 Fall;15(3):37-40 - PubMed
  16. Clin Hemorheol Microcirc. 2012;50(3):221-5 - PubMed
  17. Thrombosis. 2012;2012:956962 - PubMed
  18. Chin Med J (Engl). 2012 May;125(9):1547-51 - PubMed
  19. J Thromb Thrombolysis. 2013 Jan;35(1):57-64 - PubMed
  20. Circulation. 2011 Sep 13;124(11):1283-7 - PubMed
  21. BMC Cardiovasc Disord. 2013 Dec 10;13:113 - PubMed
  22. Eur Heart J. 2011 Sep;32(17):2125-34 - PubMed
  23. Turk Kardiyol Dern Ars. 2011 Sep;39(6):463-8 - PubMed

Publication Types